![YFV YFV](https://data.pdbj.org/pdbjplus/data/cc/svg/YFV.svg) | YFV | Name: | 5-[(4-aminopiperidin-1-yl)methyl]-N-{3-[5-(propan-2-yl)-1,3,4-thiadiazol-2-yl]phenyl}pyrrolo[2,1-f][1,2,4]triazin-4-amine | Formula: | C23 H28 N8 S | SMILES: | c3(c1n(ccc1CN2CCC(CC2)N)ncn3)Nc4cccc(c4)c5sc(C(C)C)nn5 | InChi: | InChI=1S/C23H28N8S/c1-15(2)22-28-29-23(32-22)16-4-3-5-19(12-16)27-21-20-17(6-11-31(20)26-14-25-21)13-30-9-7-18(24)8-10-30/h3-6,11-12,14-15,18H,7-10,13,24H2,1-2H3,(H,25,26,27) | Definition date: | 2021-02-26 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | 5-[(4-aminopiperidin-1-yl)methyl]-N-{3-[5-(propan-2-yl)-1,3,4-thiadiazol-2-yl]phenyl}pyrrolo[2,1-f][1,2,4]triazin-4-amine |
|
![YFY YFY](https://data.pdbj.org/pdbjplus/data/cc/svg/YFY.svg) | YFY | Name: | (2R,3R)-N-[3-methoxy-4-(1,3-oxazol-5-yl)phenyl]-3-(propan-2-yl)piperidine-2-carboxamide | Formula: | C19 H25 N3 O3 | SMILES: | COc2cc(ccc2c1cnco1)NC(=O)C3C(C(C)C)CCCN3 | InChi: | InChI=1S/C19H25N3O3/c1-12(2)14-5-4-8-21-18(14)19(23)22-13-6-7-15(16(9-13)24-3)17-10-20-11-25-17/h6-7,9-12,14,18,21H,4-5,8H2,1-3H3,(H,22,23)/t14-,18-/m1/s1 | Definition date: | 2021-02-26 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | (2R,3R)-N-[3-methoxy-4-(1,3-oxazol-5-yl)phenyl]-3-(propan-2-yl)piperidine-2-carboxamide |
|
![ZKM ZKM](https://data.pdbj.org/pdbjplus/data/cc/svg/ZKM.svg) | ZKM | Name: | N-[(1S,2R,3E)-2-hydroxy-1-{[(3-O-sulfo-beta-D-galactopyranosyl)oxy]methyl}heptadec-3-en-1-yl]-hexadecanamide | Formula: | C40 H77 N O11 S | SMILES: | CCCCCCCCCCCCCC=CC(O)C(COC1OC(CO)C(O)C(OS(=O)(=O)O)C1O)NC(=O)CCCCCCCCCCCCCCC | InChi: | InChI=1S/C40H77NO11S/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-34(43)33(32-50-40-38(46)39(52-53(47,48)49)37(45)35(31-42)51-40)41-36(44)30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h27,29,33-35,37-40,42-43,45-46H,3-26,28,30-32H2,1-2H3,(H,41,44)(H,47,48,49)/b29-27+/t33-,34+,35+,37-,38+,39-,40+/m0/s1 | Definition date: | 2021-04-30 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | N-{(2S,3R,4E)-3-hydroxy-1-[(3-O-sulfo-beta-D-galactopyranosyl)oxy]octadec-4-en-2-yl}hexadecanamide |
|
![G5X G5X](https://data.pdbj.org/pdbjplus/data/cc/svg/G5X.svg) | G5X | Name: | 1-(2-azanylpyrimidin-4-yl)-6-[2-(1-oxidanylcyclohexyl)ethynyl]indole-3-carboxamide | Formula: | C21 H21 N5 O2 | SMILES: | NC(=O)c1cn(c2ccnc(N)n2)c3cc(ccc13)C#CC4(O)CCCCC4 | InChi: | InChI=1S/C21H21N5O2/c22-19(27)16-13-26(18-7-11-24-20(23)25-18)17-12-14(4-5-15(16)17)6-10-21(28)8-2-1-3-9-21/h4-5,7,11-13,28H,1-3,8-9H2,(H2,22,27)(H2,23,24,25) | Definition date: | 2020-07-30 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | 1-(2-azanylpyrimidin-4-yl)-6-[2-(1-oxidanylcyclohexyl)ethynyl]indole-3-carboxamide |
|
![XNG XNG](https://data.pdbj.org/pdbjplus/data/cc/svg/XNG.svg) | XNG | Name: | 4-(decanoylamino)butanoic acid | Formula: | C14 H27 N O3 | SMILES: | C(CCC(=O)O)NC(CCCCCCCCC)=O | InChi: | InChI=1S/C14H27NO3/c1-2-3-4-5-6-7-8-10-13(16)15-12-9-11-14(17)18/h2-12H2,1H3,(H,15,16)(H,17,18) | Definition date: | 2020-12-22 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | 4-(decanoylamino)butanoic acid |
|
![Z7S Z7S](https://data.pdbj.org/pdbjplus/data/cc/svg/Z7S.svg) | Z7S | Name: | N-[(2S,3S,4R,5R,6R)-4,5-dihydroxy-2,6-bis(hydroxymethyl)piperidin-3-yl]acetamide | Formula: | C9 H18 N2 O5 | SMILES: | OC1C(O)C(NC(C)=O)C(CO)NC1CO | InChi: | InChI=1S/C9H18N2O5/c1-4(14)10-7-5(2-12)11-6(3-13)8(15)9(7)16/h5-9,11-13,15-16H,2-3H2,1H3,(H,10,14)/t5-,6-,7+,8-,9-/m1/s1 | Definition date: | 2021-04-12 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | N-[(2S,3S,4R,5R,6R)-4,5-dihydroxy-2,6-bis(hydroxymethyl)piperidin-3-yl]acetamide |
|
![Z8V Z8V](https://data.pdbj.org/pdbjplus/data/cc/svg/Z8V.svg) | Z8V | Name: | N-[(2R,3S,4R,5R,6R)-4,5-dihydroxy-2,6-bis(hydroxymethyl)piperidin-3-yl]acetamide | Formula: | C9 H18 N2 O5 | SMILES: | OC1C(O)C(NC(C)=O)C(CO)NC1CO | InChi: | InChI=1S/C9H18N2O5/c1-4(14)10-7-5(2-12)11-6(3-13)8(15)9(7)16/h5-9,11-13,15-16H,2-3H2,1H3,(H,10,14)/t5-,6+,7-,8+,9+/m0/s1 | Definition date: | 2021-04-12 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | N-[(2R,3S,4R,5R,6R)-4,5-dihydroxy-2,6-bis(hydroxymethyl)piperidin-3-yl]acetamide |
|
![Y6P Y6P](https://data.pdbj.org/pdbjplus/data/cc/svg/Y6P.svg) | Y6P | Name: | 7-methyl-3-(1~{H}-pyrazol-4-yl)-1~{H}-indole-2-carboxylic acid | Formula: | C13 H11 N3 O2 | SMILES: | Cc1cccc2c1[nH]c(C(O)=O)c2c3c[nH]nc3 | InChi: | InChI=1S/C13H11N3O2/c1-7-3-2-4-9-10(8-5-14-15-6-8)12(13(17)18)16-11(7)9/h2-6,16H,1H3,(H,14,15)(H,17,18) | Definition date: | 2021-02-08 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | 7-methyl-3-(1~{H}-pyrazol-4-yl)-1~{H}-indole-2-carboxylic acid |
|
![ZHM ZHM](https://data.pdbj.org/pdbjplus/data/cc/svg/ZHM.svg) | ZHM | Name: | 2-(2,5-dibromophenoxy)-6-[4-methyl-1-(piperidin-4-yl)-1H-1,2,3-triazol-5-yl]pyridine | Formula: | C19 H19 Br2 N5 O | SMILES: | Brc1cc(Oc2cccc(n2)c2c(C)nnn2C2CCNCC2)c(Br)cc1 | InChi: | InChI=1S/C19H19Br2N5O/c1-12-19(26(25-24-12)14-7-9-22-10-8-14)16-3-2-4-18(23-16)27-17-11-13(20)5-6-15(17)21/h2-6,11,14,22H,7-10H2,1H3 | Definition date: | 2021-04-29 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | 2-(2,5-dibromophenoxy)-6-[4-methyl-1-(piperidin-4-yl)-1H-1,2,3-triazol-5-yl]pyridine |
|
![ZHS ZHS](https://data.pdbj.org/pdbjplus/data/cc/svg/ZHS.svg) | ZHS | Name: | 2-(4-{5-[6-(3,5-dimethylphenoxy)pyridin-2-yl]-4-methyl-1H-1,2,3-triazol-1-yl}piperidin-1-yl)-N,N-dimethylethan-1-amine | Formula: | C25 H34 N6 O | SMILES: | Cc1cc(cc(C)c1)Oc1cccc(n1)c1c(C)nnn1C1CCN(CCN(C)C)CC1 | InChi: | InChI=1S/C25H34N6O/c1-18-15-19(2)17-22(16-18)32-24-8-6-7-23(26-24)25-20(3)27-28-31(25)21-9-11-30(12-10-21)14-13-29(4)5/h6-8,15-17,21H,9-14H2,1-5H3 | Definition date: | 2021-04-29 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | 2-(4-{5-[6-(3,5-dimethylphenoxy)pyridin-2-yl]-4-methyl-1H-1,2,3-triazol-1-yl}piperidin-1-yl)-N,N-dimethylethan-1-amine |
|
![ZHV ZHV](https://data.pdbj.org/pdbjplus/data/cc/svg/ZHV.svg) | ZHV | Name: | 2-(4-{5-[6-(2,5-dibromophenoxy)pyridin-2-yl]-4-methyl-1H-1,2,3-triazol-1-yl}piperidin-1-yl)-N,N-dimethylethan-1-amine | Formula: | C23 H28 Br2 N6 O | SMILES: | Brc1cc(Oc2cccc(n2)c2c(C)nnn2C2CCN(CCN(C)C)CC2)c(Br)cc1 | InChi: | InChI=1S/C23H28Br2N6O/c1-16-23(31(28-27-16)18-9-11-30(12-10-18)14-13-29(2)3)20-5-4-6-22(26-20)32-21-15-17(24)7-8-19(21)25/h4-8,15,18H,9-14H2,1-3H3 | Definition date: | 2021-04-29 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | 2-(4-{5-[6-(2,5-dibromophenoxy)pyridin-2-yl]-4-methyl-1H-1,2,3-triazol-1-yl}piperidin-1-yl)-N,N-dimethylethan-1-amine |
|
![GG0 GG0](https://data.pdbj.org/pdbjplus/data/cc/svg/GG0.svg) | GG0 | Name: | 2-(2-azanylethanoylamino)ethanoic acid | Formula: | C4 H8 N2 O3 | SMILES: | NCC(=O)NCC(O)=O | InChi: | InChI=1S/C4H8N2O3/c5-1-3(7)6-2-4(8)9/h1-2,5H2,(H,6,7)(H,8,9) | Definition date: | 2020-08-07 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | 2-(2-azanylethanoylamino)ethanoic acid |
|
![GOU GOU](https://data.pdbj.org/pdbjplus/data/cc/svg/GOU.svg) | GOU | Name: | 6-chloranyl-9-[(3-propan-2-yl-1,2-oxazol-5-yl)methyl]purin-2-amine | Formula: | C12 H13 Cl N6 O | SMILES: | CC(C)c1cc(Cn2cnc3c(Cl)nc(N)nc23)on1 | InChi: | InChI=1S/C12H13ClN6O/c1-6(2)8-3-7(20-18-8)4-19-5-15-9-10(13)16-12(14)17-11(9)19/h3,5-6H,4H2,1-2H3,(H2,14,16,17) | Definition date: | 2020-09-16 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | 6-chloranyl-9-[(3-propan-2-yl-1,2-oxazol-5-yl)methyl]purin-2-amine |
|
![GQ0 GQ0](https://data.pdbj.org/pdbjplus/data/cc/svg/GQ0.svg) | GQ0 | Name: | 9-[(3-tert-butyl-1,2-oxazol-5-yl)methyl]-6-chloranyl-purin-2-amine | Formula: | C13 H15 Cl N6 O | SMILES: | CC(C)(C)c1cc(Cn2cnc3c(Cl)nc(N)nc23)on1 | InChi: | InChI=1S/C13H15ClN6O/c1-13(2,3)8-4-7(21-19-8)5-20-6-16-9-10(14)17-12(15)18-11(9)20/h4,6H,5H2,1-3H3,(H2,15,17,18) | Definition date: | 2020-09-16 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | 9-[(3-~{tert}-butyl-1,2-oxazol-5-yl)methyl]-6-chloranyl-purin-2-amine |
|
![GQ3 GQ3](https://data.pdbj.org/pdbjplus/data/cc/svg/GQ3.svg) | GQ3 | Name: | 9-[(3-tert-butyl-1,2-oxazol-5-yl)methyl]-6-chloranyl-purin-2-amine | Formula: | C13 H17 Cl N6 O | SMILES: | CC(C)(C)C1=NO[CH](Cn2cnc3c(Cl)nc(N)nc23)C1 | InChi: | InChI=1S/C13H17ClN6O/c1-13(2,3)8-4-7(21-19-8)5-20-6-16-9-10(14)17-12(15)18-11(9)20/h6-7H,4-5H2,1-3H3,(H2,15,17,18)/t7-/m1/s1 | Definition date: | 2020-09-16 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | 9-[(3-~{tert}-butyl-4,5-dihydro-1,2-oxazol-5-yl)methyl]-6-chloranyl-purin-2-amine |
|
![GQ6 GQ6](https://data.pdbj.org/pdbjplus/data/cc/svg/GQ6.svg) | GQ6 | Name: | 6-chloranyl-9-[(4-methylphenyl)methyl]purin-2-amine | Formula: | C13 H12 Cl N5 | SMILES: | Cc1ccc(Cn2cnc3c(Cl)nc(N)nc23)cc1 | InChi: | InChI=1S/C13H12ClN5/c1-8-2-4-9(5-3-8)6-19-7-16-10-11(14)17-13(15)18-12(10)19/h2-5,7H,6H2,1H3,(H2,15,17,18) | Definition date: | 2020-09-16 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | 6-chloranyl-9-[(4-methylphenyl)methyl]purin-2-amine |
|
![GQ9 GQ9](https://data.pdbj.org/pdbjplus/data/cc/svg/GQ9.svg) | GQ9 | Name: | 6-chloranyl-9-[(2-phenyl-1,3-oxazol-5-yl)methyl]purin-2-amine | Formula: | C15 H11 Cl N6 O | SMILES: | Nc1nc(Cl)c2ncn(Cc3oc(nc3)c4ccccc4)c2n1 | InChi: | InChI=1S/C15H11ClN6O/c16-12-11-13(21-15(17)20-12)22(8-19-11)7-10-6-18-14(23-10)9-4-2-1-3-5-9/h1-6,8H,7H2,(H2,17,20,21) | Definition date: | 2020-09-16 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | 6-chloranyl-9-[(2-phenyl-1,3-oxazol-5-yl)methyl]purin-2-amine |
|
![1AI 1AI](https://data.pdbj.org/pdbjplus/data/cc/svg/1AI.svg) | 1AI | Name: | ~{N}-[(2-methylphenyl)methyl]-3-[(2-methylphenyl)methylamino]pyrazine-2-carboxamide | Formula: | C21 H22 N4 O | SMILES: | Cc1ccccc1CNC(=O)c2nccnc2NCc3ccccc3C | InChi: | InChI=1S/C21H22N4O/c1-15-7-3-5-9-17(15)13-24-20-19(22-11-12-23-20)21(26)25-14-18-10-6-4-8-16(18)2/h3-12H,13-14H2,1-2H3,(H,23,24)(H,25,26) | Definition date: | 2021-06-09 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | ~{N}-[(2-methylphenyl)methyl]-3-[(2-methylphenyl)methylamino]pyrazine-2-carboxamide |
|
![1FI 1FI](https://data.pdbj.org/pdbjplus/data/cc/svg/1FI.svg) | 1FI | Name: | 3-[[2-(trifluoromethyl)phenyl]methylamino]pyrazine-2-carboxamide | Formula: | C13 H11 F3 N4 O | SMILES: | NC(=O)c1nccnc1NCc2ccccc2C(F)(F)F | InChi: | InChI=1S/C13H11F3N4O/c14-13(15,16)9-4-2-1-3-8(9)7-20-12-10(11(17)21)18-5-6-19-12/h1-6H,7H2,(H2,17,21)(H,19,20) | Definition date: | 2021-06-09 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | 3-[[2-(trifluoromethyl)phenyl]methylamino]pyrazine-2-carboxamide |
|
![GUC GUC](https://data.pdbj.org/pdbjplus/data/cc/svg/GUC.svg) | GUC | Name: | N-[3-[(3S)-1-azanyl-5-fluoranyl-3-methyl-4H-2,6-naphthyridin-3-yl]-4-fluoranyl-phenyl]-5-cyano-3-methyl-pyridine-2-carboxamide | Formula: | C23 H18 F2 N6 O | SMILES: | Cc1cc(cnc1C(=O)Nc2ccc(F)c(c2)[C]3(C)Cc4c(F)nccc4C(=N3)N)C#N | InChi: | InChI=1S/C23H18F2N6O/c1-12-7-13(10-26)11-29-19(12)22(32)30-14-3-4-18(24)17(8-14)23(2)9-16-15(21(27)31-23)5-6-28-20(16)25/h3-8,11H,9H2,1-2H3,(H2,27,31)(H,30,32)/t23-/m0/s1 | Definition date: | 2020-09-24 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | ~{N}-[3-[(3~{S})-1-azanyl-5-fluoranyl-3-methyl-4~{H}-2,6-naphthyridin-3-yl]-4-fluoranyl-phenyl]-5-cyano-3-methyl-pyridine-2-carboxamide |
|
![QPB QPB](https://data.pdbj.org/pdbjplus/data/cc/svg/QPB.svg) | QPB | Name: | methyl (~{Z})-3-(4-hydroxyphenyl)-2-methyl-prop-2-enoate | Formula: | C11 H12 O3 | SMILES: | COC(=O)C(C)=Cc1ccc(O)cc1 | InChi: | InChI=1S/C11H12O3/c1-8(11(13)14-2)7-9-3-5-10(12)6-4-9/h3-7,12H,1-2H3/b8-7- | Definition date: | 2020-07-16 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | methyl (~{Z})-3-(4-hydroxyphenyl)-2-methyl-prop-2-enoate |
|
![QPE QPE](https://data.pdbj.org/pdbjplus/data/cc/svg/QPE.svg) | QPE | Name: | methyl (~{Z})-2-methyl-3-phenyl-prop-2-enoate | Formula: | C11 H12 O2 | SMILES: | COC(=O)C(C)=Cc1ccccc1 | InChi: | InChI=1S/C11H12O2/c1-9(11(12)13-2)8-10-6-4-3-5-7-10/h3-8H,1-2H3/b9-8- | Definition date: | 2020-07-16 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | methyl (~{Z})-2-methyl-3-phenyl-prop-2-enoate |
|
![QPK QPK](https://data.pdbj.org/pdbjplus/data/cc/svg/QPK.svg) | QPK | Name: | 3-chloranyl-2,6-bis(fluoranyl)phenol | Formula: | C6 H3 Cl F2 O | SMILES: | Oc1c(F)ccc(Cl)c1F | InChi: | InChI=1S/C6H3ClF2O/c7-3-1-2-4(8)6(10)5(3)9/h1-2,10H | Definition date: | 2020-07-17 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | 3-chloranyl-2,6-bis(fluoranyl)phenol |
|
![QPN QPN](https://data.pdbj.org/pdbjplus/data/cc/svg/QPN.svg) | QPN | Name: | 1-[1-(3-fluorophenyl)-6,7-dihydro-4~{H}-pyrazolo[4,3-c]pyridin-5-yl]propan-1-one | Formula: | C15 H16 F N3 O | SMILES: | CCC(=O)N1CCc2n(ncc2C1)c3cccc(F)c3 | InChi: | InChI=1S/C15H16FN3O/c1-2-15(20)18-7-6-14-11(10-18)9-17-19(14)13-5-3-4-12(16)8-13/h3-5,8-9H,2,6-7,10H2,1H3 | Definition date: | 2020-07-17 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | 1-[1-(3-fluorophenyl)-6,7-dihydro-4~{H}-pyrazolo[4,3-c]pyridin-5-yl]propan-1-one |
|
![QTB QTB](https://data.pdbj.org/pdbjplus/data/cc/svg/QTB.svg) | QTB | Name: | (3~{E},5~{E},7~{E})-6-methyl-8-[(6~{R})-2,2,6-trimethylcyclohexyl]octa-3,5,7-trien-2-one | Formula: | C18 H28 O | SMILES: | C[CH]1CCCC(C)(C)[CH]1C=CC(C)=CC=CC(C)=O | InChi: | InChI=1S/C18H28O/c1-14(8-6-10-16(3)19)11-12-17-15(2)9-7-13-18(17,4)5/h6,8,10-12,15,17H,7,9,13H2,1-5H3/b10-6+,12-11+,14-8+/t15-,17+/m1/s1 | Definition date: | 2020-08-06 | Last modified: | 2021-07-23 | Release date: | 2021-07-28 | Identifier: | (3~{E},5~{E},7~{E})-6-methyl-8-[(6~{R})-2,2,6-trimethylcyclohexyl]octa-3,5,7-trien-2-one |
|